4YTC

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2015-08-12	Initial release
1.1	2015-08-19		Other
1.2	2015-09-23		Database references
1.3	2015-10-07		Database references
1.4	2024-11-06		Data collection, Database references, Derived calculations, Structure summary	chem_comp_atom, chem_comp_bond, citation, database_2, pdbx_entry_details, pdbx_modification_feature, pdbx_struct_oper_list	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.